ARTICLE | Company News
Arisyn Therapeutics, University of Arizona Foundation deal
October 6, 2008 7:00 AM UTC
Arisyn acquired a portfolio of the foundation's small molecule inhibitors to treat cancer and viral diseases. The deal includes candidates in Phase I testing to treat HIV and cancer and preclinical co...